Skip to main content

LIVE

NMTC

NeuroOne Medical Technologies Corporation

NMTC

NASDAQ·Healthcare·Medical - Devices·Mkt cap $14.1M

$1.06

▲ +2.91%

P/E

-1.25

Mkt Cap

$14.1M

52-Wk Range

$1.01–$6.96

52-Week Range

$1.01 - $6.96

P/E

-1.25

Fwd P/E

-1.67

Beta

0.64

Div Yield

0.00%

Avg Vol

46.2K

Shares Out

8.4M

Mkt Cap

$14.1M

Price action

Price chart

Down 80.7% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Proprietary thin film electrode technology enabling simultaneous recording and ablation
  • Strategic partnership with RBC Medical Innovations for advanced ablation systems
  • Focused expertise in underserved neurological disorder markets
  • Innovation in minimally invasive neurotech solutions
▼

Bear Case

1 risk

  • Low volatility (beta 0.6).

Growth

Strong growth ahead

Rising prevalence of epilepsy and neurological disorders globally

Value

Deep value opportunity - significant discount to sector peers

Momentum

Falling

-65.7% over 3m

Quality

Strong

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Dec 15, 2026

“
Q3 26 RECAP

AUG 13, 2026

Reported EPS of -$0.28 vs -$0.21 consensus (-33.3% surprise). Revenue of $2.0M vs $2.2M expected (-8.9%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-33.3%

Revenue trend · last 8Q

—

—

—

+1%

+105%

+907%

-12%

+16%

Q3 24

Q4 24

Q1 24

Q2 25

Q3 25

Q4 25

Q1 25

Q3 26

$825.8K

$272.3K

$3.3M

$1.4M

$1.7M

$2.7M

$2.9M

$2.0M

Margins · last 8Q

Gross

59.9%

Operating

-122.9%

Profit

-101.7%

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

—

Latest: Ladenburg Thalmann · May 13, 2026

vs Industry

How NMTC stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.